LUNAC THERAPEUTICS

lunac-therapeutics-logo

Epidarex Capital invests in early-stage, high growth life science and health technology Epidarex Capital is a transatlantic venture fund that invests in early-stage, high growth life science and health technology companies in under-ventured markets.

#People #Financial #Event #Website #More

LUNAC THERAPEUTICS

Industry:
Biotechnology Therapeutics

Founded:
2018-04-18

Address:
Leeds, Leeds, United Kingdom

Country:
United Kingdom

Website Url:
http://www.lunactherapeutics.com

Total Employee:
1+

Status:
Active

Total Funding:
10.54 M GBP

Technology used in webpage:
Microsoft Exchange Online Organization Schema Person Schema



Current Advisors List

carl-sterritt_image

Carl Sterritt Strategic Advisor @ Lunac Therapeutics
Advisor
2020-09-01

Current Employees Featured

not_available_image

Helen Philippou
Helen Philippou Scientific Co-Founder @ Lunac Therapeutics
Scientific Co-Founder

not_available_image

Richard Foster
Richard Foster Scientific Co-Founder @ Lunac Therapeutics
Scientific Co-Founder

Founder


not_available_image

Helen Philippou

not_available_image

Richard Foster

Investors List

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Venture Round - Lunac Therapeutics

northern-powerhouse-investment-fund_image

Northern Powerhouse Investment Fund

Northern Powerhouse Investment Fund investment in Venture Round - Lunac Therapeutics

caribou-property_image

Caribou Property

Caribou Property investment in Venture Round - Lunac Therapeutics

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Lunac Therapeutics

epidarex-capital_image

Epidarex Capital

Epidarex Capital investment in Series A - Lunac Therapeutics

university-of-leeds-england_image

University of Leeds

University of Leeds investment in Series A - Lunac Therapeutics

Key Employee Changes

Date New article
2020-11-26 Lunac Therapeutics appoints new chief

Official Site Inspections

http://www.lunactherapeutics.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Lunac Therapeutics"

LUNAC Therapeutics | Anticoagulant Discovery

At LUNAC Therapeutics we're developing a first-in-class, next generation oral and intravenous anticoagulants for the treatment and prevention of life-threatening thrombotic events, without โ€ฆSee details»

Our Science - Lunac Therapeutics

Based on unique biological insights generated in the laboratory of founding scientist Professor Helen Philippou, LUNAC is focused on the development of a new class of oral and intravenous anticoagulants.See details»

LUNAC Therapeutics Appoints Julian Howell as Chief โ€ฆ

Leeds, UK, 29 September 2021: LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the development of advanced life-saving anticoagulants, is pleased to announce the appointment of Julian Howell as โ€ฆSee details»

LUNAC Therapeutics - LinkedIn

LUNAC Therapeutics is a spin out from the University of Leeds, UK and is pursuing the discovery of next generation oral anticoagulant therapies with a reduced risk of causing bleeding compared to...See details»

Lunac Therapeutics - Crunchbase Company Profile & Funding

Where is Lunac Therapeutics's headquarters? Lunac Therapeutics is located in Leeds, Leeds, United Kingdom. Who invested in Lunac Therapeutics? Lunac Therapeutics has 5 investors โ€ฆSee details»

Lunac Therapeutics Ltd.: Drug pipelines, Patents, Clinical trials

Explore Lunac Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

LUNAC Therapeutics - University of Leeds

LUNAC Therapeutics is a drug discovery company focused on the identification and development of next generation anticoagulant therapeutics by targeting activated Factor XII (activated โ€ฆSee details»

LUNAC Therapeutics appoints Carl Sterritt as Chief Executive Officer

Nov 26, 2020ย ยท LUNAC Therapeutics Ltd (LUNAC), a UK-based drug discovery company focused on the development of advanced life-saving anticoagulants with minimal risk of bleeding, โ€ฆSee details»

LUNAC Therapeutics Completes Additional Financing Round

Leeds, UK, 13 May 2021: LUNAC Therapeutics (LUNAC), a UK-based drug discovery company focused on the development of advanced life-saving anticoagulants, announces it has raised โ€ฆSee details»

LUNAC Therapeutics - PitchBook

Developer of advanced oral anticoagulant drugs designed to treat and prevent life-threatening thrombotic events. The company's drugs help to minimize the bleeding risk in patients, โ€ฆSee details»

Lunac Therapeutics Ltd - VentureRadar

Website: https://www.lunactherapeutics.com/ Develops next-generation anti-thrombotic treatments aiming to protect patients from blood clots without severe bleeding risks, currently โ€ฆSee details»

LUNAC Therapeutics - Company Profile - Tracxn

Nov 17, 2024ย ยท Developer of therapeutics to prevent blood clots. The company has developed an oral small molecule anticoagulant that inhibits the activated clotting factor called enzyme โ€ฆSee details»

LUNAC Therapeutics appoints Carl Sterritt as Chief Executive

Leeds, UK, 25 November 2020: LUNAC Therapeutics Ltd (LUNAC), a UK-based drug discovery company focused on the development of advanced life-saving anticoagulants with minimal risk โ€ฆSee details»

Lunac Therapeutics led project wins U.K. innovation grant worth โ€ฆ

Dec 3, 2019ย ยท Lunacโ€™s research has shown that targeting activated Factor XII has the potential to offer a new treatment option for patients, and we are therefore delighted to have secured โ€ฆSee details»

LUNAC Therapeutics wins 'Start Up of the Year' at Medilink โ€ฆ

Leeds, UK, 25 June 2021: LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the development of advanced life-saving anticoagulants has been announced as โ€ฆSee details»

LUNAC Therapeutics Completes Additional Financing Round

Leeds, UK, 13 May 2021: LUNAC Therapeutics (LUNAC), a UK-based drug discovery company focused on the development of advanced life-saving anticoagulants, announces it has raised โ€ฆSee details»

LUNAC Therapeutics Wins Start Up of the Year at Bionow Awards

LUNAC Therapeutics is a spin out from the University of Leeds pursuing the discovery of next generation oral anticoagulant therapies with a reduced risk of causing bleeding compared to โ€ฆSee details»

LUNAC Therapeutics Shortlisted for Medilink Healthcare Business โ€ฆ

Jun 25, 2021ย ยท For more information, please go to www.lunactherapeutics.com. Follow LUNAC on Twitter @LUNACtx1.See details»

LUNAC Therapeutics - Products, Competitors, Financials, โ€ฆ

LUNAC Therapeutics is a company focused on the development of anticoagulant therapies in the healthcare and pharmaceutical industry.See details»

Privacy Policy - Lunac Therapeutics

LUNAC Therapeutics Limited of LUNAC Therapeutics, Nexus, Discovery Way, Leeds, Yorks, England, LS2 3AA (โ€œweโ€ โ€œourโ€ โ€œusโ€) are committed to protecting and respecting your privacy.See details»

linkstock.net © 2022. All rights reserved